USE OF BACITRACIN A IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING CORONAVIRUSES
Provided by the present invention is the use of bacitracin A in the preparation of drugs for preventing and treating coronaviruses. Specifically, disclosed is the use of bacitracin A or pharmaceutically acceptable salts, isotopes, stereoisomers, mixtures of stereoisomers, tautomers, esters, amides, or prodrugs thereof in the preparation of drugs for preventing and/or treating diseases caused by coronaviruses. The coronaviruses are the novel coronaviruses SARS-CoV-2, SARS-CoV, HCoV 229E, NL63, OC43, HKU1, and MERS-CoV..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 25. Nov. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
YUAN SHUGUANG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-11-25, Last update posted on www.tib.eu: 2023-10-19, Last updated: 2023-10-27 |
|---|
| Patentnummer: |
WO2021203704 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA01257113X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA01257113X | ||
| 003 | DE-627 | ||
| 005 | 20231027104345.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA01257113X | ||
| 035 | |a (EPA)WO2021203704 | ||
| 035 | |a (EPA)71555801 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a YUAN SHUGUANG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a USE OF BACITRACIN A IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING CORONAVIRUSES |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-11-25, Last update posted on www.tib.eu: 2023-10-19, Last updated: 2023-10-27 | ||
| 520 | |a Provided by the present invention is the use of bacitracin A in the preparation of drugs for preventing and treating coronaviruses. Specifically, disclosed is the use of bacitracin A or pharmaceutically acceptable salts, isotopes, stereoisomers, mixtures of stereoisomers, tautomers, esters, amides, or prodrugs thereof in the preparation of drugs for preventing and/or treating diseases caused by coronaviruses. The coronaviruses are the novel coronaviruses SARS-CoV-2, SARS-CoV, HCoV 229E, NL63, OC43, HKU1, and MERS-CoV. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a CHEN XIANCHONG |4 aut | |
| 700 | 0 | |a LUO MUPENG |4 aut | |
| 700 | 0 | |a CUI WENQIANG |4 aut | |
| 700 | 0 | |a ZOU RONGFENG |4 aut | |
| 700 | 0 | |a ZHAO JINCUN |4 aut | |
| 700 | 0 | |a SUN JING |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 25. Nov. |
| 773 | 1 | 8 | |g year:2021 |g day:25 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/71555801/publication/WO2021203704A1?q=WO2021203704 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2021 |b 25 |c 11 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 25 |c 11 | ||